Literature DB >> 17507407

Drosophila Nemo antagonizes BMP signaling by phosphorylation of Mad and inhibition of its nuclear accumulation.

Yi Arial Zeng1, Maryam Rahnama, Simon Wang, Worlanyo Sosu-Sedzorme, Esther M Verheyen.   

Abstract

Drosophila Nemo is the founding member of the Nemo-like kinase (Nlk) family of serine/threonine protein kinases that are involved in several Wnt signal transduction pathways. Here we report a novel function for Nemo in the inhibition of bone morphogenetic protein (BMP) signaling. Genetic interaction studies demonstrate that nemo can antagonize BMP signaling and can inhibit the expression of BMP target genes during wing development. Nemo can bind to and phosphorylate the BMP effector Mad. In cell culture, phosphorylation by Nemo blocks the nuclear accumulation of Mad by promoting export of Mad from the nucleus in a kinase-dependent manner. This is the first example of the inhibition of Drosophila BMP signaling by a MAPK and represents a novel mechanism of Smad inhibition through the phosphorylation of a conserved serine residue within the MH1 domain of Mad.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507407     DOI: 10.1242/dev.02853

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  31 in total

Review 1.  Strategies for exploring TGF-β signaling in Drosophila.

Authors:  Aidan J Peterson; Michael B O'Connor
Journal:  Methods       Date:  2014-03-27       Impact factor: 3.608

2.  Inwardly rectifying potassium channels influence Drosophila wing morphogenesis by regulating Dpp release.

Authors:  Giri Raj Dahal; Sarala Joshi Pradhan; Emily Anne Bates
Journal:  Development       Date:  2017-07-06       Impact factor: 6.868

3.  NLK positively regulates Wnt/β-catenin signalling by phosphorylating LEF1 in neural progenitor cells.

Authors:  Satoshi Ota; Shizuka Ishitani; Nobuyuki Shimizu; Kunihiro Matsumoto; Motoyuki Itoh; Tohru Ishitani
Journal:  EMBO J       Date:  2012-02-28       Impact factor: 11.598

4.  Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis.

Authors:  Jun Ohshima; Qian Wang; Zackary R Fitzsimonds; Daniel P Miller; Maryta N Sztukowska; Young-Jung Jung; Mikako Hayashi; Marvin Whiteley; Richard J Lamont
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

5.  Nemo phosphorylates Eyes absent and enhances output from the Eya-Sine oculis transcriptional complex during Drosophila retinal determination.

Authors:  Santiago A Morillo; Lorena R Braid; Esther M Verheyen; Ilaria Rebay
Journal:  Dev Biol       Date:  2012-02-25       Impact factor: 3.582

6.  Nemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

7.  Nemo regulates cell dynamics and represses the expression of miple, a midkine/pleiotrophin cytokine, during ommatidial rotation.

Authors:  Verónica Muñoz-Soriano; Carlos Ruiz; Manuel Pérez-Alonso; Marek Mlodzik; Nuria Paricio
Journal:  Dev Biol       Date:  2013-02-18       Impact factor: 3.582

8.  Human SMAD4 is phosphorylated at Thr9 and Ser138 by interacting with NLK.

Authors:  Yan Shi; Kan Ye; Huiling Wu; Yixing Sun; Huili Shi; Keke Huo
Journal:  Mol Cell Biochem       Date:  2009-08-19       Impact factor: 3.396

9.  Mad is required for wingless signaling in wing development and segment patterning in Drosophila.

Authors:  Edward Eivers; Luis C Fuentealba; Veronika Sander; James C Clemens; Lori Hartnett; E M De Robertis
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

10.  Nemo kinase interacts with Mad to coordinate synaptic growth at the Drosophila neuromuscular junction.

Authors:  Carlos Merino; Jay Penney; Miranda González; Kazuya Tsurudome; Myriam Moujahidine; Michael B O'Connor; Esther M Verheyen; Pejmun Haghighi
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.